Management Of A High-risk Rare Primary Cardiac Lymphoma

Radha Gopalan,Kevin Lin,McEwan Hopkins,Andres Vargas Rodriguez,Ambar Andrade,Michael Morris,Farouk Mookadam

DOI: https://doi.org/10.1016/j.cardfail.2023.10.158

IF: 6.592

2024-01-01

Journal of Cardiac Failure

Abstract:Introduction Cardiac lymphomas are rare and can be fatal if not diagnosed and treated appropriately. They are commonly diffuse large B cell lymphomas (DLBCL) presenting with secondary cardiac involvement. Primary cardiac lymphomas are rarer with an incidence rate of 0.25%. Patients typically have heart failure symptoms, which can confound diagnosis with more common etiologies. Masses are often identified by imaging, but further modalities and tissue biopsy are required to identify the etiology before pursuing treatment. We discuss a rare case of a primary DLBCL arising from the interventricular septum. Case Presentation A 47-year-old woman with a PMH of DLBCL of the right groin in 2017 was in remission after chemotherapy. She presented with symptoms of chest pressure, dyspnea, palpitations, and dizziness. A CT angiogram was ordered to evaluate pulmonary embolism resulted with hypoenhancement of the right ventricle (RV). Echocardiography subsequently revealed a homogenous mass in the RV causing massive RV dilatation and hypokinesis, and compression of the LV (Fig. 1). Cardiac MRI demonstrated invasion of the mass into the interventricular septum and wall of the LV, making her a poor candidate for surgical resection. Biopsy of the mass by pathology identified it as DLBCL. The patient was started on rituximab, ifosfamide, carboplatin, and etoposide. Serial echocardiography was performed during treatment with the mass regressing to a third of its original size without cardiac perforation (Fig. 2). After clinical improvement, she was discharged and returned to her previous oncologists for continued treatment. Discussion Primary cardiac lymphomas are rare. Once diagnosed, the treatment includes aggressive chemotherapy or surgical resection. Masses arising from the structures of the heart have the potential to cause cardiac perforation and subsequent demise of the patient during regression. These patients can be successfully managed with multidisciplinary involvement and careful monitoring.

cardiac & cardiovascular systems